Why this doctor returned to Genentech to give hemophilia patients a shot

Dr. Gallia Levy saw the early clinical data around a potential hemophilia A drug that Roche affiliate Chugai Pharmaceutical had developed. Now it was coming to Genentech, and Levy wanted to be there, too.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news